A Study Of Acute Kidney Injury Survivor Experience

Overview

About this study

The purpose of this study is to characterize the AKI survivor experience and the impact of ACT on patients in the rural setting.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults (≥18 years)

  • Documented stage 2 or 3 AKI during hospitalization

  • Anticipated discharge to home

  • No current requirement for dialysis

  • No enrollment in hospice

  • Care Partners

    • Self-identified as the primary care partner by the patient

Exclusion Criteria:

  • No vulnerable populations (prisoners, pregnant women, fetuses, neonates, or children)

 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/01/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Erin Barreto, Pharm.D., Ph.D., R.Ph., BCCCP

Contact us for the latest status

Contact information:

Justin Webster

5072844317

webster.justin@mayo.edu

More information

Publications

Publications are currently not available